• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

PLAG1 免疫组化是鉴别多形性腺瘤的一个敏感标志物:与 PLAG1 基因异常的比较研究。

PLAG1 immunohistochemistry is a sensitive marker for pleomorphic adenoma: a comparative study with PLAG1 genetic abnormalities.

机构信息

Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.

出版信息

Histopathology. 2018 Jan;72(2):285-293. doi: 10.1111/his.13341. Epub 2017 Oct 19.

DOI:10.1111/his.13341
PMID:28796899
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5730461/
Abstract

AIMS

Pleomorphic adenoma gene 1 (PLAG1) gene rearrangement is the most common genetic abnormality in pleomorphic adenoma (PA), resulting in overexpression of PLAG1 protein. PA and carcinoma ex pleomorphic adenoma (CA ex-PA) can mimic various benign and malignant salivary gland tumours. The aims of this study are to evaluate the sensitivity and specificity of PLAG1 immunohistochemistry (IHC) in the differential diagnosis of PA and CA ex-PA and to compare the PLAG1 immunohistochemical results to PLAG1 gene abnormalities as detected by fluorescence in-situ hybridisation (FISH).

METHODS AND RESULTS

PLAG1 immunostaining was performed on 83 salivary gland tumours, including 23 PA, 15 CA ex-PA and 45 other salivary gland tumours. In addition, PLAG1 FISH was performed in 44 cases for the presence of gene rearrangements/amplifications. The results showed high sensitivity of PLAG1 IHC in 96% of PA; however, discordant results between PLAG1 FISH abnormalities and IHC were noted in 15 of 44 cases (34%). Seven PA, four de-novo myoepithelial carcinomas and one basal cell adenocarcinoma had negative FISH results, but were positive for IHC; while three salivary duct carcinomas (SDC) ex-PA were positive for FISH but negative for IHC. PLAG1 IHC can differentiate CA ex-PA from de-novo SDC (P = 0.02), but not from de-novo myoepithelial carcinoma. PLAG1 IHC is a sensitive marker for PA. This could be due to PLAG1 gene abnormalities beyond FISH resolution.

CONCLUSIONS

A negative PLAG1 IHC might be helpful in excluding a PA diagnosis. Interestingly, in the context of CA ex-PA, FISH is more sensitive than IHC in detecting PLAG1 abnormalities.

摘要

目的

多形性腺瘤基因 1(PLAG1)基因重排是多形性腺瘤(PA)中最常见的遗传异常,导致 PLAG1 蛋白过表达。PA 和癌旁多形性腺瘤(CA ex-PA)可模拟各种良性和恶性涎腺肿瘤。本研究旨在评估 PLAG1 免疫组化(IHC)在 PA 和 CA ex-PA 鉴别诊断中的敏感性和特异性,并将 PLAG1 免疫组化结果与荧光原位杂交(FISH)检测到的 PLAG1 基因异常进行比较。

方法和结果

对 83 例涎腺肿瘤进行了 PLAG1 免疫组化染色,包括 23 例 PA、15 例 CA ex-PA 和 45 例其他涎腺肿瘤。此外,对 44 例进行了 PLAG1 FISH 以检测基因重排/扩增。结果显示,PA 中 PLAG1 IHC 的敏感性高达 96%;然而,在 44 例中有 15 例(34%)出现 PLAG1 FISH 异常与 IHC 结果不一致。7 例 PA、4 例原发性肌上皮癌和 1 例基底细胞腺癌 FISH 结果阴性,但 IHC 阳性;而 3 例 CA ex-PA 则 FISH 阳性而 IHC 阴性。PLAG1 IHC 可将 CA ex-PA 与原发性涎腺癌(SDC)区分开(P=0.02),但不能与原发性肌上皮癌区分开。PLAG1 IHC 是 PA 的敏感标志物。这可能是由于 PLAG1 基因异常超出了 FISH 的分辨率。

结论

PLAG1 IHC 阴性可能有助于排除 PA 诊断。有趣的是,在 CA ex-PA 中,FISH 在检测 PLAG1 异常方面比 IHC 更敏感。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cfbc/5730461/677b2bd71a28/nihms898929f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cfbc/5730461/07b44728bd87/nihms898929f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cfbc/5730461/677b2bd71a28/nihms898929f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cfbc/5730461/07b44728bd87/nihms898929f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cfbc/5730461/677b2bd71a28/nihms898929f2.jpg

相似文献

1
PLAG1 immunohistochemistry is a sensitive marker for pleomorphic adenoma: a comparative study with PLAG1 genetic abnormalities.PLAG1 免疫组化是鉴别多形性腺瘤的一个敏感标志物:与 PLAG1 基因异常的比较研究。
Histopathology. 2018 Jan;72(2):285-293. doi: 10.1111/his.13341. Epub 2017 Oct 19.
2
Recurrent rearrangements of the PLAG1 and HMGA2 genes in lacrimal gland pleomorphic adenoma and carcinoma ex pleomorphic adenoma.PLAG1 和 HMGA2 基因在泪腺多形性腺瘤和癌在多形性腺瘤中的反复重排。
Acta Ophthalmol. 2018 Nov;96(7):e768-e771. doi: 10.1111/aos.13667. Epub 2018 Feb 13.
3
Consistent PLAG1 and HMGA2 abnormalities distinguish carcinoma ex-pleomorphic adenoma from its de novo counterparts.一致的PLAG1和HMGA2异常可将多形性腺瘤癌变与其原发性对应物区分开来。
Hum Pathol. 2015 Jan;46(1):26-33. doi: 10.1016/j.humpath.2014.08.017. Epub 2014 Sep 7.
4
Subsets of salivary duct carcinoma defined by morphologic evidence of pleomorphic adenoma, PLAG1 or HMGA2 rearrangements, and common genetic alterations.根据多形性腺瘤的形态学证据、PLAG1 或 HMGA2 重排以及常见基因改变定义的涎腺导管癌亚型。
Cancer. 2016 Oct 15;122(20):3136-3144. doi: 10.1002/cncr.30179. Epub 2016 Jul 5.
5
PLAG1 alteration in carcinoma ex pleomorphic adenoma: immunohistochemical and fluorescence in situ hybridization studies of 22 cases.多形性腺瘤癌变中PLAG1改变:22例病例的免疫组织化学和荧光原位杂交研究
Head Neck Pathol. 2012 Sep;6(3):328-35. doi: 10.1007/s12105-012-0353-8. Epub 2012 Apr 8.
6
An analysis of PLAG1 and HMGA2 rearrangements in salivary duct carcinoma and examination of the role of precursor lesions.唾液腺癌中 PLAG1 和 HMGA2 重排的分析及前病变作用的研究。
Histopathology. 2013 Aug;63(2):250-62. doi: 10.1111/his.12152. Epub 2013 Jun 6.
7
Diagnostic utility of PLAG1 immunohistochemical determination in salivary gland tumors.PLAG1免疫组化检测在涎腺肿瘤中的诊断效用
Appl Immunohistochem Mol Morphol. 2014 May-Jun;22(5):390-4. doi: 10.1097/PAI.0b013e3182936ea7.
8
PLAG1 gene alterations in salivary gland pleomorphic adenoma and carcinoma ex-pleomorphic adenoma: a combined study using chromosome banding, in situ hybridization and immunocytochemistry.涎腺多形性腺瘤和多形性腺瘤癌变中PLAG1基因改变:一项联合应用染色体显带、原位杂交和免疫细胞化学的研究
Mod Pathol. 2005 Aug;18(8):1048-55. doi: 10.1038/modpathol.3800386.
9
What is hiding behind S100 protein and SOX10 positive oncocytomas? Oncocytic pleomorphic adenoma and myoepithelioma with novel gene fusions in a subset of cases.S100 蛋白和 SOX10 阳性嗜酸细胞瘤背后隐藏着什么?在某些病例中,嗜酸细胞多形性腺瘤和肌上皮瘤存在新的基因融合。
Hum Pathol. 2020 Sep;103:52-62. doi: 10.1016/j.humpath.2020.07.009. Epub 2020 Jul 13.
10
Epithelial-Myoepithelial Carcinoma: Frequent Morphologic and Molecular Evidence of Preexisting Pleomorphic Adenoma, Common HRAS Mutations in PLAG1-intact and HMGA2-intact Cases, and Occasional TP53, FBXW7, and SMARCB1 Alterations in High-grade Cases.上皮-肌上皮癌:常见的形态学及分子学证据显示其起源于多形性腺瘤,PLAG1和HMGA2未发生改变的病例中常见HRAS突变,高级别病例中偶见TP53、FBXW7及SMARCB1改变 。
Am J Surg Pathol. 2018 Jan;42(1):18-27. doi: 10.1097/PAS.0000000000000933.

引用本文的文献

1
The Evaluation of Blood Prooxidant-Antioxidant Balance Indicators and Cortisol Pre- and Post-Surgery in Patients with Benign Parotid Gland Tumors: A Preliminary Study.腮腺良性肿瘤患者手术前后血液促氧化剂-抗氧化剂平衡指标及皮质醇的评估:一项初步研究
J Clin Med. 2025 Aug 1;14(15):5425. doi: 10.3390/jcm14155425.
2
Histologic characteristics and predictors of outcome in epithelial-myoepithelial carcinoma (EMC) of salivary gland: a multi-center study of 75 cases.涎腺上皮-肌上皮癌(EMC)的组织学特征及预后预测因素:一项 75 例的多中心研究
Virchows Arch. 2025 Jul 2. doi: 10.1007/s00428-025-04159-6.
3
Basal cell adenoma with S100 protein-positive "stroma": a distinct triphasic salivary gland neoplasm characterized by CTNNB1 mutation.

本文引用的文献

1
Loss of expression of Plag1 in malignant transformation from pleomorphic adenoma to carcinoma ex pleomorphic adenoma.在多形性腺瘤向多形性腺瘤癌变的恶性转化过程中Plag1表达缺失。
Hum Pathol. 2016 Nov;57:152-159. doi: 10.1016/j.humpath.2016.07.011. Epub 2016 Jul 26.
2
PLAG1: An Immunohistochemical Marker with Limited Utility in Separating Pleomorphic Adenoma from Other Basaloid Salivary Gland Tumors.PLAG1:一种在鉴别多形性腺瘤与其他基底样唾液腺肿瘤方面效用有限的免疫组织化学标志物。
Acta Cytol. 2016;60(3):240-5. doi: 10.1159/000447622. Epub 2016 Jul 28.
3
PLAG1 expression is maintained in recurrent pleomorphic adenoma.
伴有S100蛋白阳性“间质”的基底细胞腺瘤:一种以CTNNB1突变为特征的独特的三相性涎腺肿瘤。
Virchows Arch. 2025 Jun 14. doi: 10.1007/s00428-025-04141-2.
4
Correlation between basal cell adenoma and basal cell adenocarcinoma of the salivary gland: a histomorphological and molecular review of 129 cases.涎腺基底细胞腺瘤与基底细胞腺癌的相关性:129例病例的组织形态学及分子学综述
Virchows Arch. 2025 May 13. doi: 10.1007/s00428-025-04120-7.
5
Comprehensive pan-cancer analysis identifies PLAG1 as a key regulator of tumor immune microenvironment and prognostic biomarker.全面的泛癌分析确定PLAG1是肿瘤免疫微环境的关键调节因子和预后生物标志物。
Front Immunol. 2025 Apr 10;16:1572108. doi: 10.3389/fimmu.2025.1572108. eCollection 2025.
6
An Institutional Experience of Core Needle Biopsy with Cooperative Implementation by Pathologists and Head and Neck Oncologists in Salivary Gland Carcinoma.头颈部肿瘤医师与病理医师合作实施核心针活检的机构经验:唾液腺癌。
Head Neck Pathol. 2024 Nov 19;18(1):122. doi: 10.1007/s12105-024-01725-3.
7
Distinct copy number signatures between residual benign and transformed areas of carcinoma ex pleomorphic adenoma.癌在多形性腺瘤中残留良性与转化区之间存在独特的拷贝数特征。
Sci Rep. 2024 Oct 9;14(1):23645. doi: 10.1038/s41598-024-63763-9.
8
Calcineurin-mediated dephosphorylation stabilizes E2F1 protein by suppressing binding of the FBXW7 ubiquitin ligase subunit.钙调神经磷酸酶介导的去磷酸化通过抑制 FBXW7 泛素连接酶亚基的结合来稳定 E2F1 蛋白。
Proc Natl Acad Sci U S A. 2024 Oct 8;121(41):e2414618121. doi: 10.1073/pnas.2414618121. Epub 2024 Oct 3.
9
Proceedings of the 2024 North American Society of Head and Neck Pathology Companion Meeting, Baltimore, MD, March 24, 2024: Navigating Ancillary Studies in Basaloid/Blue Salivary Tumors.2024 年北美头颈部病理学会联合会议记录,马里兰州巴尔的摩,2024 年 3 月 24 日:蓝细胞性基底细胞样唾液腺瘤的辅助检查解读。
Head Neck Pathol. 2024 Mar 25;18(1):24. doi: 10.1007/s12105-024-01626-5.
10
Oncocytoid Salivary Tumors: Differential Diagnosis and Utility of Newly Described Immunohistochemistry.腺样囊性唾液腺瘤:鉴别诊断和新描述的免疫组织化学的应用。
Head Neck Pathol. 2024 Mar 19;18(1):20. doi: 10.1007/s12105-024-01622-9.
PLAG1表达在复发性多形性腺瘤中持续存在。
Virchows Arch. 2016 Oct;469(4):477-81. doi: 10.1007/s00428-016-1980-3. Epub 2016 Jul 6.
4
Subsets of salivary duct carcinoma defined by morphologic evidence of pleomorphic adenoma, PLAG1 or HMGA2 rearrangements, and common genetic alterations.根据多形性腺瘤的形态学证据、PLAG1 或 HMGA2 重排以及常见基因改变定义的涎腺导管癌亚型。
Cancer. 2016 Oct 15;122(20):3136-3144. doi: 10.1002/cncr.30179. Epub 2016 Jul 5.
5
Usefulness of translocation-associated immunohistochemical stains in the fine-needle aspiration diagnosis of salivary gland neoplasms.易位相关免疫组化染色在涎腺肿瘤细针穿刺诊断中的应用价值
Cancer Cytopathol. 2016 Jun;124(6):397-405. doi: 10.1002/cncy.21693. Epub 2016 Feb 16.
6
Integrated data analysis reveals uterine leiomyoma subtypes with distinct driver pathways and biomarkers.综合数据分析揭示了具有不同驱动途径和生物标志物的子宫平滑肌瘤亚型。
Proc Natl Acad Sci U S A. 2016 Feb 2;113(5):1315-20. doi: 10.1073/pnas.1518752113. Epub 2016 Jan 19.
7
Emerging role of PLAG1 as a regulator of growth and reproduction.PLAG1作为生长和繁殖调节因子的新作用。
J Endocrinol. 2016 Feb;228(2):R45-56. doi: 10.1530/JOE-15-0449. Epub 2015 Nov 17.
8
Consistent PLAG1 and HMGA2 abnormalities distinguish carcinoma ex-pleomorphic adenoma from its de novo counterparts.一致的PLAG1和HMGA2异常可将多形性腺瘤癌变与其原发性对应物区分开来。
Hum Pathol. 2015 Jan;46(1):26-33. doi: 10.1016/j.humpath.2014.08.017. Epub 2014 Sep 7.
9
Tumours of the lacrimal gland. Epidemiological, clinical and genetic characteristics.泪腺肿瘤。流行病学、临床及遗传学特征。
Acta Ophthalmol. 2013 Nov;91 Thesis 6:1-28. doi: 10.1111/aos.12271.
10
Lacrimal gland pleomorphic adenoma and carcinoma ex pleomorphic adenoma: genomic profiles, gene fusions, and clinical characteristics.泪腺多形性腺瘤和癌在多形性腺瘤中的基因组特征、基因融合和临床特征。
Ophthalmology. 2014 May;121(5):1125-33. doi: 10.1016/j.ophtha.2013.11.037. Epub 2014 Jan 24.